FKBP14

Across TCGA pan-cancer cohorts, FKBP14 mass-spec protein differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of FKBP14’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where FKBP14 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types FKBP14 is over-expressed in tumor.

HNSC, CCRCC, and LSCC are the cancer types where FKBP14 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in FKBP14 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	IV	+0.955	<.001	11	view →
CCRCC	Female	All	+0.621	<.001	11	view →
LSCC	Male	All	+1.056	<.001	9	view →
LUAD	Male	III,IV	+1.013	<.001	8	view →
PDAC	Female	II,III,IV	+0.891	<.001	5	view →
COAD	All	All	+0.360	.016	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

FKBP14–HNSC

Open the HNSC breakdown →